Miglustat (N-Butyldeoxynojirimycin) is an orally active and reversible ceramide glucosyltransferase inhibitor. Miglustat can be used for the research of type I gaucher disease[1].
Molecular Weight:
219.28
Purity:
99.86
CAS Number:
[72599-27-0]
Formula:
C10H21NO4
Target:
Glucosylceramide Synthase (GCS)
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
